Urothelial Cancer Clinical Trials

Find Urothelial Cancer Clinical Trials Near You

Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

To collect, process, store, and study biological samples and related clinical and imaging data from participants with known or suspected urothelial carcinoma or another related malignancy of the urinary tract.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Eligibility Criteria

⁃ Participants must meet all of the following criteria for enrollment:

• Age 18 years or older at the time of consent.

• Known or suspected urothelial carcinoma or other related malignancy of the urinary tract for which biospecimen and associated clinical data collection is relevant to the objectives of this protocol. This may include patients undergoing diagnostic evaluation for a lesion, mass, abnormal cytology, or other clinical finding concerning for malignancy.

• Undergoing evaluation, treatment, surveillance, follow-up care, or clinically indicated procedures at The University of Texas M.D. Anderson Cancer Center, including Houston Area Locations.

• Able to understand and personally provide informed consent.

• Willing to allow prospective collection, banking, storage, and research use of biospecimens and associated clinical information as described in the informed consent document.

Locations
United States
Texas
UT MD Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
Byron Lee, MD
BHLee@mdanderson.org
713-792-3250
Time Frame
Start Date: 2026-09-10
Estimated Completion Date: 2038-12-31
Participants
Target number of participants: 50000
Related Therapeutic Areas
Sponsors
Leads: M.D. Anderson Cancer Center

This content was sourced from clinicaltrials.gov